Online inquiry

IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK5101MR)

This product GTTS-WK5101MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the Intestinal Alkaline Phosphatase protein. This product can be used in -related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001631
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification oligo-dT affinity purification
Target Gene
Gene ID 248
UniProt ID P09923
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK5101MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK1357MR IVTScrip™ mRNA-Human PBLD, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA PBLD
GTTS-WK19511MR IVTScrip™ mRNA-Human AGPAT5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AGPAT5
GTTS-WK17259MR IVTScrip™ mRNA-Human AMPD3, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA AMPD3
GTTS-WK3680MR IVTScrip™ mRNA-Human CD156b, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA CD156b
GTTS-WK21977MR IVTScrip™ mRNA-Human ARG2, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARG2
GTTS-WK16614MR IVTScrip™ mRNA-Human ALG14, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ALG14
GTTS-WK22167MR IVTScrip™ mRNA-Human ATL2, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ATL2
GTTS-WK11772MR IVTScrip™ mRNA-Human ABHD8, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ABHD8
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW